District Court Rejects ViroPharma Motion to Block Vancocin Generics

The U.S. District Court for the District of Columbia has denied ViroPharma’s motion for a temporary injunction to require the FDA to withdraw its approval of three generics of the gastrointestinal antibiotic Vancocin. The company filed a complaint and restraining order in the district court after the FDA rejected its 2006 citizen petition protesting changes to bioequivalence standards for Vancocin (vancomycin HCl) generics.
Washington Drug Letter